학술논문
Visnnodegib (VISMO), a hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study primary analysis in 1215 patients (pts).
Document Type
ConferencePaper
Author
Source
JOURNAL OF CLINICAL ONCOLOGY. 34(15)
Subject
Language
English
English
English
ISSN
0732-183X